ANI Pharmaceuticals to Present at the H.C. Wainwright Bioconnect Virtual Conference

Rhea-AI Summary

ANI Pharmaceuticals will present virtually at the H.C. Wainwright Bioconnect Conference on January 10, 2022, at 7:00 a.m. ET. The presentation will feature CEO Nikhil Lalwani and CFO Stephen Carey. The webcast will be available on demand starting at the specified time and will remain archived for 90 days on ANI's website. ANI Pharmaceuticals focuses on providing high-quality branded and generic pharmaceutical products, particularly for diseases with unmet medical needs. For more details, visit www.anipharmaceuticals.com.

BAUDETTE, Minn.--(BUSINESS WIRE)-- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present virtually at the H.C. Wainwright Bioconnect Conference as follows:

Date:					Monday, January 10, 2022
On Demand:					7:00 a.m. ET
Webcast:					https://journey.ct.events/view/5e7687b5-9c3a-4a19-b96c-88ad184d5c59

The webcast will be accessible on demand beginning on January 10, 2022, at 7:00 a.m. ET and archived for 90 days thereafter, via the Company’s website at www.anipharmaceuticals.com, under the Investors section.

About ANI

ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by building a successful Purified Cortrophin™ Gel franchise, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220103005452/en/

Investor Relations:

Lisa M. Wilson, In-Site Communications, Inc.

T: 212-452-2793

E: lwilson@insitecony.com

Media:

Angela Salerno-Robin

dna Communications

T: 212-445-8219

E: ASalerno-Robin@dna-comms.com

Source: ANI Pharmaceuticals, Inc.

FAQ

When is ANI Pharmaceuticals' presentation at the H.C. Wainwright Bioconnect Conference?

ANI Pharmaceuticals will present on January 10, 2022, at 7:00 a.m. ET.

Who is presenting for ANI Pharmaceuticals at the H.C. Wainwright Bioconnect Conference?

CEO Nikhil Lalwani and CFO Stephen Carey will represent ANI Pharmaceuticals.

How can I access the ANI Pharmaceuticals conference presentation?

The presentation will be available on demand at www.anipharmaceuticals.com starting January 10, 2022.

How long will the ANI Pharmaceuticals presentation be available for viewing?

The webcast will be archived for 90 days after the live presentation.

What does ANI Pharmaceuticals focus on in its business?

ANI Pharmaceuticals develops, manufactures, and markets branded and generic prescription products, especially for high unmet medical needs.